38056806|t|Aureusidin ameliorates 6-OHDA-induced neurotoxicity via activating Nrf2/HO-1 signaling pathway and preventing mitochondria-dependent apoptosis pathway in SH-SY5Y cells and Caenorhabditis elegans.
38056806|a|Movement disorder Parkinson's disease (PD) is the second most common neurodegenerative disease in the world after Alzheimer's disease, which severely affects the quality of patients' lives and imposes an increasingly heavy socioeconomic burden. Aureusidin is a kind of natural flavonoid compound with anti-inflammatory and anti-oxidant activities, while its pharmacological action and mechanism are rarely reported in PD. This study aimed to explore the neuroprotective effects and potential mechanisms of Aureusidin in PD. The present study demonstrated that Aureusidin protected SH-SY5Y cells from cell damage induced by 6-hydroxydopamine (6-OHDA) via inhibiting the mitochondria-dependent apoptosis and activating the Nrf2/HO-1 antioxidant signaling pathway. Additionally, Aureusidin diminished dopaminergic (DA) neuron degeneration induced by 6-OHDA and reduced the aggregation toxicity of alpha-synuclein (alpha-Syn) in Caenorhabditis elegans (C. elegans.) In conclusion, Aureusidin showed a neuroprotective effect in the 6-OHDA-induced PD model via activating Nrf2/HO-1 signaling pathway and prevented mitochondria-dependent apoptosis pathway, and these findings suggested that Aureusidin may be an effective drug for the treatment of PD.
38056806	0	10	Aureusidin	Chemical	MESH:C416232
38056806	23	29	6-OHDA	Chemical	MESH:D016627
38056806	38	51	neurotoxicity	Disease	MESH:D020258
38056806	67	71	Nrf2	Gene	4780
38056806	72	76	HO-1	Gene	3162
38056806	154	161	SH-SY5Y	CellLine	CVCL:0019
38056806	196	233	Movement disorder Parkinson's disease	Disease	MESH:D010300
38056806	235	237	PD	Disease	MESH:D010300
38056806	265	290	neurodegenerative disease	Disease	MESH:D019636
38056806	310	329	Alzheimer's disease	Disease	MESH:D000544
38056806	441	451	Aureusidin	Chemical	MESH:C416232
38056806	473	482	flavonoid	Chemical	MESH:D005419
38056806	502	514	inflammatory	Disease	MESH:D007249
38056806	614	616	PD	Disease	MESH:D010300
38056806	702	712	Aureusidin	Chemical	MESH:C416232
38056806	716	718	PD	Disease	MESH:D010300
38056806	756	766	Aureusidin	Chemical	MESH:C416232
38056806	777	784	SH-SY5Y	CellLine	CVCL:0019
38056806	819	836	6-hydroxydopamine	Chemical	MESH:D016627
38056806	838	844	6-OHDA	Chemical	MESH:D016627
38056806	917	921	Nrf2	Gene	4780
38056806	922	926	HO-1	Gene	3162
38056806	972	982	Aureusidin	Chemical	MESH:C416232
38056806	994	1008	dopaminergic (	Disease	MESH:D009422
38056806	1008	1031	DA) neuron degeneration	Disease	MESH:D009410
38056806	1043	1049	6-OHDA	Chemical	MESH:D016627
38056806	1078	1086	toxicity	Disease	MESH:D064420
38056806	1173	1183	Aureusidin	Chemical	MESH:C416232
38056806	1223	1229	6-OHDA	Chemical	MESH:D016627
38056806	1238	1240	PD	Disease	MESH:D010300
38056806	1262	1266	Nrf2	Gene	4780
38056806	1267	1271	HO-1	Gene	3162
38056806	1380	1390	Aureusidin	Chemical	MESH:C416232
38056806	1437	1439	PD	Disease	MESH:D010300
38056806	Negative_Correlation	MESH:D016627	MESH:D009422
38056806	Negative_Correlation	MESH:D005419	MESH:D007249
38056806	Association	MESH:D010300	3162
38056806	Positive_Correlation	MESH:C416232	3162
38056806	Positive_Correlation	MESH:D016627	MESH:D010300
38056806	Negative_Correlation	MESH:C416232	MESH:D020258
38056806	Positive_Correlation	MESH:D016627	MESH:D009410
38056806	Association	3162	4780
38056806	Positive_Correlation	MESH:C416232	4780
38056806	Positive_Correlation	MESH:D016627	MESH:D020258
38056806	Negative_Correlation	MESH:C416232	MESH:D009422
38056806	Negative_Correlation	MESH:C416232	MESH:D016627
38056806	Negative_Correlation	MESH:C416232	MESH:D064420
38056806	Negative_Correlation	MESH:C416232	MESH:D010300
38056806	Negative_Correlation	MESH:C416232	MESH:D007249
38056806	Negative_Correlation	MESH:C416232	MESH:D009410

